Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2200065502Phase 4Recruiting
Phase 4, randomised trial in Portal Hypertension (PH) and None comparing Alfentanil PCA with Fentanyl PCA (2 arms). Primary endpoint: Mean NRS score at T1–T3. Started Oct 2022; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2200065502.